DOCSLIB.ORG

October 2020, Pages 401–500 Volume 31, Number 5 Indexed With

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
October 2020, Pages 401–500 Volume 31, Number 5 Indexed With Indexed with IndMED ISSN 0971-0876 Indexed with MedIND RNI 50798/1990 Indian Citation Index (ICI) University Grants Commission 20737/15554 www.ijcpgroup.com A Multispecialty Journal Volume 31, Number 5 October 2020, Pages 401–500 Single Copy Rs. 300/- Peer Reviewed Journal y Review Article y Clinical Study y Case Report y Medicolegal y Medical Voice for Policy Change y Around the Globe y Spiritual Update y Inspirational Story y Lighter Reading Full text online: http://ebook.ijcpgroup.com/ijcp/ www.emedinexus.com IJCP Publications | https://goo.gl/j2nXQQ One Stop for All Diagnostics MRI CT Scan Health Packages Latest MRI by Siemens 16- Multislice Spiral CT Executive Health Check Up Ultra Short Magnet = No Claustrophobia Safest Scanner Risk Categories 1st MRI in India on VC 15 Platform Least Radiation Dose Age Based Health Packages Fully Automated Digital Pathology Laboratory - NABL Accredited Immunology Biochemistry Haematology Special Tests Contact Us S-63 Greater Kailash Part 1 Opposite M Block Market, New Delhi 110048 Tel.: 011- 41234567 Online Submission IJCP Group of Publications A Multispecialty Journal Dr Sanjiv Chopra Group Consultant Editor Volume 31, Number 5, October 2020 Dr Deepak Chopra FROM THE DESK OF THE GROUP editor-IN-CHIEF Chief Editorial Advisor 405 CMAAO IMA Consensus Statement on Protocol Recommended by CMAAO-IMA to Reduce Mortality Dr KK Aggarwal among Healthcare Workers in Asian Countries with Group Editor-in-Chief Special Focus on Resource-limited Countries KK Aggarwal Dr Veena Aggarwal Group Executive Editor REVIEW ARTICLE Mr Nilesh Aggarwal 410 Types and Classification of Nerve Injury: A Review CEO R Jayasri Krupaa, KMK Masthan, Aravintha Babu N, Sona B Ms Naina Ahuja 413 Ivermectin – A Potent Weapon in the Anti-COVID-19 COO Armamentarium Surya Kant, Harsh Rastogi, Jyoti Bajpai, KK Aggarwal Dr Anoop Misra 422 Flow Cytometer: The Need of Modern Hematology Group Advisor Laboratory Harshita Dubey, Amar Ranjan, Mansi Modi, Rimlee Dutta, Lawanya Ranjan, Luxmi Devi, Smriti Khatri Editorial Advisors CLINICAL STUDY Obstetrics and Gynaecology Dr Alka Kriplani 428 Transobturator Tape for Female Stress Incontinence: Our Experience Cardiology M Gopi Kishore, Sainadh AV Dr Sameer Srivastava Paediatrics 434 A Cross-sectional Study on Prescribing Pattern for Dr Swati Y Bhave Children at Primary Healthcare Clinics Archana Jorige, Lohitha B, Lavanya SL ENT Dr Chanchal Pal 437 Hospital Course and Comorbidity Profile of Swine Flu Gastroenterology (H1N1) Deaths in a Tertiary Care Hospital, Southern Dr Ajay Kumar and Dr Rajiv Khosla Rajasthan Rajath Rao UR, Archana Gokhroo Dermatology Dr Anil Ganjoo 443 A Comparative Study to Analyze the Association of Metabolic Syndrome in Females with Diagnosed Oncology Polycystic Ovarian Syndrome Dr PK Julka Richa Singh, Saroj Singh, Poonam Yadav, Harpreet Kaur Anand Gopal Bhatnagar Editorial Anchor CASE REPORT Advisory Bodies Heart Care Foundation of India 447 Accidental Instillation of Superglue in External Ear: A Unique Foreign Body Non-Resident Indians Chamber of Commerce & Industry World Fellowship of Religions Rupender K Ranga, SPS Yadav, Priya Malik, Ayesha Goyal This journal is indexed in IndMED (http://indmed.nic.in) and full-text of articles are included in medIND 449 An Enigma of Lower Airway Mucormycosis Infection databases (http://mednic.in) hosted by National Vijay Kumar Chennamchetty, MV Raghavendra Rao, Mahendra Kumar Verma, Informatics Centre, New Delhi. Sanjay Kumar Agarwal, Neha Agarwal, Lakshmi Hitesh Billa, Venkat Mohan Gaddam CASE REPORT Published, Printed and Edited by Dr KK Aggarwal, on behalf of 456 Multifocal Intracerebral Hemorrhages: A Rare IJCP Publications Ltd. and Presentation in a Patient of Cerebral Venous Sinus Published at E - 219, Greater Kailash Part - 1 Thrombosis New Delhi - 110 048 Mahesh Dave, Aniruddha Burli, Nagaraj, Ayush Agarwal E-mail: [email protected] Printed at 460 An Unusual Presentation of Bickerstaff Brainstem New Edge Communications Pvt. Ltd., New Delhi Encephalitis E-mail: [email protected] Arvind Vyas, Amit Kumar Bagaria, Chandrajeet Singh Ranawat, Mridula Singh Copyright 2020 IJCP Publications Ltd. All rights reserved. The copyright for all the editorial material contained 462 Paraparesis Following Spinal Anesthesia in a Patient in this journal, in the form of layout, content After Cesarean Section: A Rare Entity including images and design, is held by IJCP Publications Ltd. No part of this publication may be Pallab Kumar Mistri, Bandana Biswas, Tapan Kumar Naskar, Suhrita De, published in any form whatsoever without the prior Sujata Dalai, Sibsankar Barman written permission of the publisher. Editorial Policies MEDICOLEGAL The purpose of IJCP Academy of CME is to 464 Clinical Aspect to Admit a Patient Under MBBS serve the medical profession and provide Doctors and Specialist print continuing medical education as a part of their social commitment. The information and KK Aggarwal, Ira Gupta opinions presented in IJCP group publications reflect the views of the authors, not those of the journal, unless so stated. Advertising is MEDICAL VOICE FOR POLICY CHANGE accepted only if judged to be in harmony with the purpose of the journal; however, IJCP group 472 Medtalks with Dr KK Aggarwal reserves the right to reject any advertising at its sole discretion. Neither acceptance nor rejection constitutes an endorsement by IJCP group of AROUND THE GLOBE a particular policy, product or procedure. We believe that readers need to be aware of any 482 News and Views affiliation or financial relationship (employment, consultancies, stock ownership, honoraria, etc.) between an author and any organization or SPIRITUAL UPDATE entity that has a direct financial interest in the subject matter or materials the author is writing 490 The Skill of Controlling Anger about. We inform the reader of any pertinent KK Aggarwal relationships disclosed. A disclosure statement, where appropriate, is published at the end of the relevant article. INSPIRATIONAL STORY Note: Indian Journal of Clinical Practice does not guarantee, directly or indirectly, the quality 492 The Hotel Clerk or efficacy of any product or service described in the advertisements or other material which is commercial in nature in this issue. LIGHTER READING 494 Lighter Side of Medicine IJCP’s Editorial & BUSINESS OFFICES Delhi Mumbai Bangalore Chennai Hyderabad Dr Veena Aggarwal Mr Nilesh Aggarwal H Chandrashekar Chitra Mohan Venugopal 9811036687 9818421222 GM Sales & GM Sales & GM Sales & E - 219, Greater Unit No: 210, 2nd Floor, Marketing Marketing Marketing Kailash, Part - I, Shreepal Complex 9845232974 9841213823 9849083558 New Delhi - 110 048 Suren Road, Near Cine 11, 2nd Cross, 40A, Ganapathypuram H. No. Cont.: 011-40587513 Magic Cinema Nanjappa Garden Main Road 16-2-751/A/70 Radhanagar, Chromepet [email protected] Doddaiah Layout First Floor [email protected] Andheri (East) Chennai - 600 044 Babusapalya Karan Bagh Mumbai - 400 093 Cont.: 22650144 Subscription Kalyananagar Post Gaddiannaram [email protected] Dinesh: 9891272006 Bangalore - 560 043 [email protected] Dil Sukh Nagar [email protected] [email protected] Hyderabad - 500 059 [email protected] GM: General Manager FROM THE DESK OF THE GROUP EDITOR-IN-CHIEF Indian Journal of Clinical Practice, Vol. 31, No. 5, October 2020 Dr KK Aggarwal President, CMAAO and HCFI Past National President, IMA Group Editor-in-Chief, IJCP Group CMAAO IMA Consensus Statement on Protocol Recommended by CMAAO-IMA to Reduce Mortality among Healthcare Workers in Asian Countries with Special Focus on Resource-limited Countries COVID-19: DEFINITION not contraindicated (Revised advisory on the use of hydroxychloroquine (HCQ) as prophylaxis for SARS- Acute manageable immunogenic thrombogenic CoV-2 infection, ICMR, 22/05/2020). This may change inflammatory notifiable viral disease. from country/state to country/state or as per WHO. PREVENTION  If HCQ is contraindicated or by choice, consider ivermectin 12 mg once a week (UP protocol 1, 7, 30  All healthcare professionals (HCPs) (caregivers) days and then once a month) (Vora A, et al. White while on duty (clinical and non-clinical areas) paper on Ivermectin as a potential therapy for COVID-19. should wear N95/FF2P/surgical 3-layered mask Indian J Tuberc. 2020;67(3):448-51). This may change (correct and consistent use). Transmission risk is from country/state to country/state or as per WHO. <0.5% with N95 mask (Y Qian, et al. Performance  Physical distancing at least 3 ft × 3 ft (6 ft × 6 ft of N95 respirators: filtration efficiency for airborne preferable); if not possible, add extra protection microbial and inert particles. Am Ind Hyg Assoc J. (double masking, gloving, personal protective 1998;59(2):128-32). equipment (PPE) kit, oral disinfectant gargles with povidone-iodine or benzydamine) (Chu DK, et al.  Consider wearing a surgical mask over N95 in OPDs (change the surgical mask after every patient Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS- examination). CoV-2 and COVID-19: a systematic review and meta-  Hand washing to be done as per World Health analysis. Lancet. 2020;395(10242):1973-87. Anderson Organization (WHO) protocol (Hand hygiene: why, DE, et al. Povidone-iodine demonstrates rapid in vitro how & when? Revised August 2009. https://www.who. virucidal activity against SARS-CoV-2, the virus int/gpsc/5may/Hand_Hygiene_Why_How_and_When_ causing COVID-19 disease. Infect Dis Ther. 2020:1-7. Brochure.pdf). Turnbull RS. Benzydamine
Load more

Recommended publications
  • Coronavirus COVID-19 Outbreak in the EU – Fundamental Rights Implications”
    Coronavirus pandemic in the EU – Fundamental Rights Implications Country: Sweden Contractor’s name: Emerga Institute Date: 2 July 2020 DISCLAIMER: This document was commissioned under contract as background material for a comparative report being prepared by the European Union Agency for Fundamental Rights (FRA) for the project “Coronavirus COVID-19 outbreak in the EU – fundamental rights implications”. The information and views contained in the document do not necessarily reflect the views or the official position of the FRA. The document is made available for transparency and information purposes only and does not constitute legal advice or legal opinion. 1 Measures taken by government/public authorities 1.1 Emergency laws/states of emergency Provide information on emergency laws/declarations of states of emergency, including actions taken by police to enforce them and court rulings concerning the legality of such measures. Please include in particular information on developments relating to the protection of the right of association/demonstration; for example, with respect to the public gatherings that took place concerning the death of George Floyd, or other such events. In Sweden, the only constitutionally protected freedom or right that has been restricted for all inhabitants in connection with the spread of the corona virus is the freedom of assembly. According to section 1 of the Ordinance on prohibition on holding public gatherings and public events (Förordning [2020:114] om förbud mot att hålla allmänna sammankomster och offentliga tillställningar), general meetings and public events with more than 50 participants may not be held within Sweden until further notice.1 All other restrictions aimed at the public are posed as recommendations from the government and/or the relevant authorities and cannot be imposed by any actions taken by the police.
    [Show full text]
  • Workshop Reports PDF 2.8 MB
    Workshop reports Data science and AI in the age of COVID-19 Reflections on the response of the UK’s data science and AI community to the COVID-19 pandemic Below are the individual reports from the research. Another example of collaboration return to a context in which advances achieved workshops that were convened by The Alan between organisations was the development of during the pandemic would not be possible Turing Institute and the Centre for Facilitation adaptive clinical trials (e.g. RECOVERY8). once the COPI regulations come to an end, in November and December 2020, following despite evidence indicating public support for Challenges the Turing’s ‘AI and data science in the age of the use of health data in research.12 COVID-19’ conference. The workshops were The ability of the data science community to Workshop participants also reported that data summarised by the facilitators and theme respond more successfully to the challenge of sources could benefit from being better linked leads, and the editorial team of the primary the pandemic was hindered by several hurdles. to each other – despite more collaboration, report then applied light editing. These reports many UKRI-funded studies (ISARIC4C,13 are a reflection of the views expressed by Better standardisation and documentation PHOSP-COVID14) are still relatively standalone. workshop participants, and do not necessarily of clinical data (and other forms of data, e.g. Connecting expertise – the right people to reflect the views of The Alan Turing Institute. location) would have been beneficial. Some positive examples of standardisation could the right data to the right problem – was Several of the reports end with references have been replicated for far wider benefit.
    [Show full text]
  • Read the Report As a PDF Exploring the Covid-19
    Contents Contents 1 About 2 Executive summary 3 Introduction 5 Landscape review 5 Key findings at this stage 6 A number of symptom trackers in the ecosystem 6 Ecosystem structure 6 Lack of collaboration 6 Lack of transparency around data collection 6 Open data availability 6 User base 7 Specific types of users 7 Location 7 Data discovery 8 Types of data 8 Observations about types of data 9 Commonly asked questions 9 Data standards 9 Representation of communities 10 Changes over time 10 Mental health and wellbeing 11 Outputs 11 Individual guidance 11 Research insights 11 Improvements to existing services 11 How does the data collected relate to the outputs? 12 The symptom tracking data ecosystem 13 The UK symptom tracking data ecosystem 13 Where is value being created in this example? 14 Barriers to impact 14 Opportunities 15 International variations 15 A single source approach 15 A more collaborative approach 16 Where is value being created in this example 17 Open Data Institute 2020 / Report Exploring the Covid-19 symptom-tracking ecosystem 1 Discussion 18 Data discovery 18 Legal complexities 18 Technical barriers 20 Trust and trustworthiness 20 Recommendations 20 Standards for data 21 Enabling hub to facilitate interactions 21 Building trust with the public through ethical approaches 22 Appendices 23 About This report has been researched and produced by the Open Data Institute, and published in January 2021. Its lead author was James Maddison with contributions from Olivier Thereaux and Jeni Tennison. If you want to share feedback by email or would like to get in touch, contact the Open Covid-19 project team at [email protected].
    [Show full text]
  • COVID Tracker That Allowed, Inter Alia, Medical Officers to Order App
    COVID-19 Technology in the EU: A BITTERSWEET VICTORY FOR HUMAN RIGHTS? May 2021 COVID-19 Technology in the EU: A Bittersweet Victory for Human Rights? Publisher This project has been supported by the Civil Liberties Union for Europe e.V European AI Fund, a collaborative initiative Ringbahnstraße 16-18-20 of the Network of European Foundations 12099 Berlin, Germany (NEF). The sole responsibility for the project www.liberties.eu lies with the organiser(s) and the content may not necessarily reflect the positions of Editor European AI Fund, NEF or European AI Orsolya Reich Fund’s Partner Foundations. Assistant Editor A grant from Digital Freedom Fund allowed Jascha Galaski initial research to be conducted in twelve EU member states for the purposes of deciding Copy Editor over possible future strategic litigation actions. Jonathan Day This work is licensed under the Creative Authors Commons Attribution 4.0 International Nikolett Aszodi (Austria, England & License. To view a copy of this license, visit Wales, France, Greece, Luxembourg, Malta, http://creativecommons.org/licenses/by/4.0/ Portugal) or send a letter to Creative Commons, PO Box 1866, Mountain View, CA 94042, USA. Jascha Galaski (Belgium, Bulgaria, Croatia, Germany, Italy, Ireland, Lithuania, Poland, Slovenia, Spain, Sweden) Oleksandra Konoplia (Czechia, Cyprus, Denmark, Estonia, Finland, Latvia, Netherlands, Slovakia) Orsolya Reich (Introduction, Hungary) 2 COVID-19 Technology in the EU: A Bittersweet Victory for Human Rights? Table of contents Introduction 4 The risks of tracing
    [Show full text]
  • Assessing SARS-Cov-2 Circulation, Variants of Concern, Non-Pharmaceutical Interventions and Vaccine Rollout in the EU/EEA, 15Th Update 10 June 2021
    RISK ASSESSMENT Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update 10 June 2021 Summary Although SARS-CoV-2 transmission remains widespread in large parts of the EU/EEA, most countries report declining trends in 14-day COVID-19 notification rates, hospital and intensive care unit (ICU) occupancy, and mortality. Many countries have initiated partial lifting of different non-pharmaceutical interventions (NPIs) that aim to reduce the degree of citizens physical contact and mobility. Since January 2021, EU/EEA countries have reported an increase in the number and proportion of SARS-CoV-2 cases of variants of concern (VOC) associated with increasing transmissibility and/or severity, with Alpha (B.1.1.7) the current dominant variant across the EU/EEA. Estimates across the region show that a large proportion of the population across Europe still remains susceptible to SARS-CoV-2 and that population immunity is far from being reached. As of 3 June, the median cumulative vaccine uptake in the EU/EEA adult population (aged 18 years and older) had reached 46.2% for at least one vaccine dose and 22.3% for the full vaccination course. The highest level of vaccine uptake was observed among the elderly aged over 80, in which the uptake reached 80.5% for at least one dose and 66.3% for full vaccination coverage. For healthcare workers, the median level of at least one dose uptake was 87% and the median uptake for the full vaccination course was 65.2%. Increased vaccine supply has allowed countries to expand eligibility for vaccination to younger age groups.
    [Show full text]
  • Attributes and Predictors of Long COVID
    LETTERS https://doi.org/10.1038/s41591-021-01292-y Attributes and predictors of long COVID Carole H. Sudre1,2,3, Benjamin Murray 1, Thomas Varsavsky1, Mark S. Graham 1, Rose S. Penfold4, Ruth C. Bowyer 5, Joan Capdevila Pujol 5, Kerstin Klaser1, Michela Antonelli1, Liane S. Canas1, Erika Molteni 1, Marc Modat1, M. Jorge Cardoso 1, Anna May5, Sajaysurya Ganesh 5, Richard Davies 5, Long H. Nguyen 6, David A. Drew 6, Christina M. Astley7, Amit D. Joshi6, Jordi Merino 8,9,10, Neli Tsereteli11, Tove Fall 12, Maria F. Gomez 11, Emma L. Duncan4, Cristina Menni 4, Frances M. K. Williams 4, Paul W. Franks 4,11, Andrew T. Chan 6, Jonathan Wolf 5, Sebastien Ourselin 1,13,14, Tim Spector 4,14 and Claire J. Steves 4,14 ✉ Reports of long-lasting coronavirus disease 2019 (COVID-19) of symptom onset (Methods)5,6. Symptom duration in these indi- symptoms, the so-called ‘long COVID’, are rising but little is viduals was compared with that in age-, sex- and body mass known about prevalence, risk factors or whether it is possible index (BMI)-matched symptomatic controls who tested negative to predict a protracted course early in the disease. We ana- for COVID-19. lyzed data from 4,182 incident cases of COVID-19 in which We then compared users with symptoms persisting over 28 d individuals self-reported their symptoms prospectively in the (LC28) to users with shorter duration of symptoms, that is, less COVID Symptom Study app1. A total of 558 (13.3%) partici- than 10 d (short COVID).
    [Show full text]
  • A Long-Term Plan for Long Covid | Institute for Global Change
    A Long-Term Plan for Long Covid BRIANNA MILLER DANIEL SLEAT Contents Foreword 3 Overview 4 Our Original Recommendations 7 Further Recommendations 15 Conclusion 17 Published at https://institute.global/policy/long-term-plan-long- covid on March 12 2021 Foreword It is now clear that over 400,000 people in the UK suffer from the debilitating effects of ongL Covid or, as it is now called officially, Post-Covid-19 Syndrome, and a proportion of these will have symptoms FOREW persisting for some years. We know more about the problem than we did back in October when we FOREW launched the first eport.r We now have a working definition, but many aspects of its cause and ORD ORD mechanisms remain unclear. Unfortunately, although it is now well recognised, we have not progressed much in the treatment of the condition. The risk factors for the condition are now clearer and, although it can affect anyone of any age, we know that long-duration symptoms are more common with increasing age and in females. Studies from the ZOE Covid Symptom Study app show that having more than five different symptoms in the first week of the illness is a predictor of much increased risk. We urgently need to focus on treatment and trials of intervention, especially at three months to see if the immune cycle that prolongs symptoms can be broken. The government has invested some targeted funds for Long Covid, but these funds don’t match the scale of the problem. There are now some specialist clinical facilities around the country, but these are still patchy and too few in number and, importantly, patients and GPs lack a clear pathway to seek information and help via dedicated websites or apps.
    [Show full text]
  • Management of Post-Acute Covid-19 in Primary Care
    PRACTICE BMJ: first published as 10.1136/bmj.m3026 on 11 August 2020. Downloaded from 1 Nuffield Department of Primary Care PRACTICE POINTER Health Sciences, University of Oxford, Oxford OX2 6GG, UK Management of post-acute covid-19 in primary care 2 West Hertfordshire Hospitals NHS Trust, Watford, UK Trisha Greenhalgh, 1 Matthew Knight, 2 Christine A’Court, 1 Maria Buxton, 3 Laiba Husain1 3 West Hertfordshire Respiratory Service – Central London Community What you need to know Box 1: A patient’s account Healthcare, London, UK • Management of covid-19 after the first three weeks My wife, kids, and I all had symptoms of presumed Correspondence to: T Greenhalgh is currently based on limited evidence covid-19 in early April 2020. They were soon fine, but I [email protected] was more unwell and ended up in bed extremely fatigued, • Cite this as: BMJ 2020;370:m3026 Approximately 10% of people experience prolonged lethargic, and without appetite for four days. illness after covid-19 http://dx.doi.org/10.1136/bmj.m3026 The only person whose symptoms persisted was myself, Published: 11 August 2020 • Many such patients recover spontaneously (if slowly) and the fatigue which I had experienced was still with holistic support, rest, symptomatic treatment, lingering in the background. From this point onwards, it and gradual increase in activity became difficult to engage fully in day to day activities • Home pulse oximetry can be helpful in monitoring with my normal energy levels. Exercise, of which I do a breathlessness fair amount, was not at all possible.
    [Show full text]
  • Safely Returning America to Work Part II Glenn S
    ACOEM GUIDANCE STATEMENT Safely Returning America to Work Part II Industry-Specific Guidance Tanisha K. Taylor, MD, MPH, MBA, Rupali Das, MD, MPH, Kathryn L. Mueller, MD, MPH, Glenn S. Pransky, MD, Philip Harber, MD, MPH, Robert K. McLellan, MD, MPH, Natalie P. Hartenbaum, MD, MPH, Amy J. Behrman, MD, Deborah R. Roy, MPH, RN, CSP, and Robert C. Blink, MD, MPH he world continues to face an unprec- critical role for the use of face coverings contact within 6 ft. of individuals that are T edented threat from the COVID-19 and respirators. suspected of being infected or infected with pandemic. Physical distancing has been The SARS-CoV-2 virus is frequently the virus, or the need for repeated or 3,4 06/05/2021 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= by http://journals.lww.com/joem from Downloaded transmitted by the respiratory route. Viral extended contact with such individuals. Downloaded identified as one of the methods of reducing transmission. As a result, businesses, containing particles in the air are often dis- Very high exposure risk refers to schools, and institutes of education were persed as either droplets or aerosol. Droplets those with high potential for exposure to from closed due to such measures as well as are larger and heavier and fall to the ground known or suspected sources of SARS-CoV- http://journals.lww.com/joem restrictions on travel and social gatherings. relatively quickly in still air. Aerosols are 2 due to medical, laboratory, or postmortem Working from home, telework, and on-line smaller particles, remain suspended for lon- procedures including health care workers meetings are now the norm.
    [Show full text]
  • The Guardian.2021.08.01 [Sun, 01 Aug 2021]
    2021.08.01 - Opinion Headlines friday 30 july 2021 2021.07.30 - Coronavirus 2021.07.30 - Spotlight 2021.07.30 - Opinion 2021.07.30 - Around the world Headlines saturday 31 july 2021 2021.07.31 - Coronavirus 2021.07.31 - Spotlight 2021.07.31 - Opinion 2021.07.31 - Around the world Headlines thursday 29 july 2021 2021.07.29 - Coronavirus 2021.07.29 - Spotlight 2021.07.29 - Opinion 2021.07.29 - Around the world 2021.08.01 - Opinion Dismissed as the unwanted Games, just how did these Olympics steal our hearts? The Observer view on the Royal Navy’s operation in the South China Sea The Observer view on the plight facing children post-Covid There’s a case for vaccine passports, but ministers are failing to make it The RNLI deserves better than Nigel Farage’s contempt I’ve been watching Nigel Farage on GB News so you don’t have to. Consider yourself lucky The climate change horseman of the apocalypse rides out – cartoon We failed so badly in Afghanistan. But to throw in the towel now would be an act of betrayal Pop maestro Simon Cowell finally bows to the public’s resounding ‘no’ vote Letters: our seaside towns are worth saving For the record Adapt or die. That is the stark challenge to living in the new world we have made | Next | Section menu | Main menu | Skip to main content Skip to navigation Advertisement US edition US edition UK edition Australian edition International edition The Guardian - Back to home Search jobs Sign inSearch News Opinion Sport Culture Lifestyle ShowMoreShow More News US news World news Environment Soccer US politics
    [Show full text]
  • The Time the Children Didn't Go to School
    THE TIME THE CHILDREN DIDN’T GO TO SCHOOL ANNABELLE HAYES FOREWORD ......................................................... 3 ACKNOWLEDGEMENTS .................................. 4 APRIL 2020 ............................................................ 5 MAY, 2020 ............................................................ 33 JUNE, 2020 .......................................................... 63 JULY, 2020 ......................................................... 102 AUGUST, 2020 .................................................... 110 SEPTEMBER, 2020 ............................................ 114 OCTOBER, 2020 ............................................... 129 NOVEMBER, 2020 ........................................... 152 DECEMBER, 2020 ............................................ 166 JANUARY, 2021 ................................................. 176 FEBRUARY, 2021 .............................................. 202 MARCH, 2021 .................................................... 223 AFTERWORD ................................................... 230 2 FOREWORD In March 2020, schools, nurseries and colleges in the United Kingdom were shut down in response to the ongoing coronavirus pandemic. By 20 March, all schools in the UK had closed to all children except those of key workers and children considered vulnerable. After a month of numbness at having all the children home, I started these diaries to document the unprecedented time when the children didn’t go to school. When the world stopped, the children didn’t – this records their
    [Show full text]
  • Next 4 Weeks Crucial to Bring Down Covid Second Wave
    Follow us on: @TheDailyPioneer facebook.com/dailypioneer RNI No. TELENG/2018/76469 Established 1864 ANALYSIS 7 MONEY 8 SPORTS 12 Published From HYDERABAD DELHI LUCKNOW GEOPOLITICS TRUMPS SURGE IN CORONAVIRUS CASES MAY CLINICAL CSK REGAIN BHOPAL RAIPUR CHANDIGARH GEOECONOMICS PUT ECONOMIC RECOVERY AT RISK TOP SPOT BHUBANESWAR RANCHI DEHRADUN VIJAYAWADA *LATE CITY VOL. 3 ISSUE 189 HYDERABAD, THURSDAY APRIL 29, 2021; PAGES 12 `3 *Air Surcharge Extra if Applicable PRABHAS-NAG ASHWIN FILM TO LAUNCH ON DIWALI { Page 11 } www.dailypioneer.com SONY'S PROFIT ZOOMS TO RECORD LEVEL US RUSHING ASSISTANCE TO INDIA TO MAHA GIVES RS 1,500 EACH TO 9.17 FOUR-DAY LOCKDOWN IN GOA FROM ON VIDEO GAMES, ‘DEMON SLAYER’ COMBAT COVID SURGE: JOE BIDEN LAKH CONSTRUCTION WORKERS TODAY AS CASES SPIKE: CM ony's January-March profit zoomed eight- ashington, Apr 28 (PTI) The US is rushing he Maharashtra government has transferred he Goa government on Wednesday fold to 107 billion yen (USD 982 million) a whole series of help, including life- Rs 1,500 in the bank accounts of each of decided to impose a strict lockdown Sfrom a year earlier as people stuck at Wsaving drugs and machinery, that India Tthe 9.17 lakh registered construction Tin the state beginning April 29 till home during the coronavirus pandemic needs to combat the massive surge in workers as assistance in view of the May 3, Chief Minister Pramod Sawant turned to the Japanese electronics and COVID-19 cases, President Joe Biden has COVID-19-induced restrictions, state said. Speaking to reporters, he said entertainment company's video games and said, as he again recalled New Delhi's Labour Minister Hasan Mushrif said on essential services and industries will other visual content.
    [Show full text]